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Degeneration of dopamine (DA) neurons in Par-
kinson’s disease (PD) causes hypokinesia, but DA
replacement therapy can elicit exaggerated voluntary
and involuntary behaviors that have been attributed
to enhancedDA receptor sensitivity in striatal projec-
tion neurons.Herewe reveal that in hemiparkinsonian
mice, striatal D1 receptor-expressing medium spiny
neurons (MSNs) directly projecting to the substantia
nigra reticulata (SNr) lose tonic presynaptic inhibition
by GABAB receptors. The absence of presynaptic
GABAB response potentiates evoked GABA release
from MSN efferents to the SNr and drives motor
sensitization. This alternative mechanism of sensiti-
zation suggests a synaptic target for PD pharmaco-
therapy.
INTRODUCTION
The motor symptoms in Parkinson’s disease (PD) are caused
by the loss of dopamine (DA) neurons of the substantia nigra
pars compacta (SNc) (Fahn, 2000), as shown by the success of
replacement therapy with the DA precursor 3,4-dihydroxy-
L-phenylalanine (L-DOPA). L-DOPA therapy, however, also gen-
erates excessive behavioral responses to environmental stimuli
(Weintraub and Nirenberg, 2013), impulse control disorders
(Voon et al., 2011), and dyskinesias (Fahn, 2000).
Studies using animal models of PD indicate that L-DOPA and
DA receptor agonists cause sensitized motor behavior due to a
denervation-induced supersensitivity of DA receptors (Marshall
and Ungerstedt, 1977). These responses can occur following
the first administration of DAergic drugs to DA-depleted animals
(Putterman et al., 2007), indicating that the DA denervation is it-
self sufficient to induce abnormal behavioral responses to drug
treatment. Indeed, dyskinesia appears rapidly in patients with
a late diagnosis of PD, and in individuals with acute parkinsonism
from the neurotoxin MPTP (Langston and Ballard, 1984) or976 Neuron 87, 976–988, September 2, 2015 ª2015 Elsevier Inc.inherited defects in DA synthesis (Pons et al., 2013). These
observations reinforce the hypothesis that adaptations to low
DA signaling contribute to the expression of side effects of
L-DOPA therapy (Nadjar et al., 2009). L-DOPA administration,
however, influences subsequent behavioral responses to the
drug (Morelli et al., 1989), and the impact of the adaptations
established without DA replacement therapy is unknown.
The striatal GABAergic medium spiny projection neurons that
are enriched in DA D1 receptors (D1R) play a central role in the
expression of sensitization to L-DOPA in DA denervated animals
(Feyder et al., 2011). The D1-MSNs give rise to the striatonigral
‘‘direct pathway,’’ sending long-range axons to the GABAergic
neurons of the substantia nigra pars reticulata (SNr) (Gerfen,
1992). Motor-stimulating striatonigral activation pauses SNr
tonic firing, disinhibiting their target nuclei in the thalamus, brain-
stem, and superior colliculus (Deniau et al., 2007). The idea that
DA denervation elicits sensitization to L-DOPA in part via stimu-
lation of the striatonigral pathway is supported by observations
that DA denervated animals exhibit increased D1R-mediated
release of GABA within the SNr (Mango et al., 2014; Rangel-Bar-
ajas et al., 2008). In addition, homeostatic changes driven by the
absence of DA lead to increased excitability of D1-MSNs, which
is not normalized by L-DOPA (Fieblinger et al., 2014; Warre et al.,
2011), indicating that adaptive responses extend beyond activa-
tion of D1Rs.Whether these changes are reflected in neurotrans-
mitter release from striatonigral synapses in the SNr and if they
are sufficient to affect behavior are unknown.
Here, we circumvented DA D1R stimulation of striatonigral
activity in DA lesioned mice using optogenetics. To measure
changes in neurotransmitter release from striatonigral terminals
subsequent to nigrostriatal DA lesion, we used patch-clamp re-
cordings and developed an optical approach to measure pre-
synaptic activity in the SNr using the fluorescent synaptic vesicle
endocytic probe FM1-43 (Betz and Bewick, 1992). Our data
demonstrate that DA denervation increases the probability of
synaptic vesicle fusion and GABA release from striatonigral
synapses, presumably as a compensatory response; that the
increased presynaptic input is due to reduced GABAB autore-
ceptor responses; and that changes in basal ganglia circuitry
that can elicit behavioral sensitization occur presynaptically at
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Figure 1. Optogenetic Stimulation of Striatonigral Synapses Re-
duces Hypokinesia and Reveals a Supersensitive Direct Pathway
in 6-OHDA Lesioned Mice
(A) Schematic of a sagittal brain slice indicating AAV5-DIO-ChR2-eYFP and
6-OHDA injection sites and the fiber optic placement. STR, striatum; SN,
substantia nigra.
(B) Oblique (10) sagittal section showing the Cre-dependent expression of
ChR2-eYFP in the striatonigral pathway 3 weeks after AAV injection into BAC
transgenic D1R-Cre mice (scale, 1 mm).
(C and D) Coronal section of (C) the dorsal striatum and (D) the SNr showing
ChR2-eYFP (yellow) and DAPI (blue) fluorescence. cc, corpus callosum. The
track of the fiber optic is outlined with arrowheads in (D) (scale, 200 mm).
(E and F) (E) Confocal micrographs of ChR2-eYFP, DARPP-32 immunoreac-
tivity, and the colocalization of the two signals in the striatum, and (F) within
striatonigral fibers rostral to the SNr.
(G–I) Effect of illuminating the SNr with flashes (5 ms) of blue light (10 Hz; 5 min)
on (G) the number of 360 contralateral turns (H) number of rearings and
(I) the time (in seconds) spent in immobility. *p < 0.05; **p < 0.01; ***p < 0.001
(two-way analysis of variance (ANOVA), Tukey’s test). n = 6 mice per group.
Mean ± SEM (see also Figures S2 and S3).MSN axons within the SNr and are independent of DA receptor
stimulation.
RESULTS
We injected 6-OHDA or vehicle unilaterally into the medial fore-
brain bundle, which contains the ascending nigrostriatal DA
projections, and confirmed contralateral sensorimotor deficits
3 weeks later in the corridor test (Grealish et al., 2010). As
sensitization to L-DOPA is observed with severe DA denervation
(Putterman et al., 2007), this paradigm was used to select mice
with an impairment which corresponds to >80% loss of striatal
DA innervation (Grealish et al., 2010) (see Figures S1A–S1D
available online). We confirmed that 6-OHDA decreased tyrosine
hydroxylase and dopamine transporter proteins in the striatum
(Figures S1E–S1G).
Expression of ChR2 in the Striatonigral Pathway
To examine striatonigral function in vivo, we administered ad-
eno-associated virus encoding channelrhodopsin-2 fused to
enhanced yellow fluorescent protein (AAV5-DIO-ChR2-eYFP)
into ipsilateral dorsal striatum of 6-OHDA and sham-treated
transgenic mice expressing Cre recombinase under control of
the D1R promoter (Figure 1A). An optical fiber was implanted
dorsal to the SNr to activate striatonigral efferents. Examination
of ChR2-eYFP expression was carried out in striatum and SNr 3–
4 weeks after surgery (Figures 1B–1F). ChR2-eYFP was found in
neurons that expressed DARPP-32 (Figure 1E), but not met-
enkephalin (Figures S2A–S2C), a selective marker for striatopal-
lidal MSNs (Gerfen et al., 1990). Furthermore, ChR2-eYFP was
not found in cells expressing choline acetyltransferase, parval-
bumin, neuropeptide Y and calretinin (Figures S2D–S2I; Table
S1), verifying that ChR2 was excluded from striatal interneurons
and that ChR2 was confined to striatonigral MSNs. Consistently,
ChR2-eYFP was expressed by DARPP-32-positive rostrocaudal
projection fibers and terminal fields within the SNr, confirming
the anterograde transport of ChR2 to striatonigral axon terminals
(Figure 1F).
Effect of Selective Stimulation of Striatonigral Synapses
Unilateral inhibition of the postsynaptic neurons in the SNr by
GABA agonists leads to dose-dependent contralateral turning
behavior in rodents (Waddington and Cross, 1979). We hypoth-
esized that the number of contralateral turns would correspond
to inhibition driven by striatonigral GABA release.
Selective stimulation of striatonigral synapses by illumination
of the ipsilateral SNr with flashes (5 ms, 5 min at 10 Hz) of
blue light produced a greater behavioral response in DA dener-
vated mice, as measured by the number of contralateral turns
performed and forward locomotion (Figures 1G and S2J–S2L;
Movie S1 and Movie S2). In the absence of optogenetic
stimulation, 6-OHDA-treated mice reared to explore the envi-
ronment infrequently (Figure 1H) and spent more time immo-
bile (Figure 1I) than sham-treated controls. These hypokinetic
phenotypes were reduced by optogenetic stimulation of the
striatonigral terminals in the SNr. The behavioral responses
were time-locked to the striatonigral activation, as rotational
behavior, the frequency of rearing, and the time spent immobileNeuron 87, 976–988, September 2, 2015 ª2015 Elsevier Inc. 977
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Figure 2. Increased Striatonigral GABA Transmission in 6-OHDA
Lesioned Mice
(A) Cell-attached recordings from SNr neurons in brain slices from sham
(black) and 6-OHDA lesioned mice (blue).
(B and C) (B) Frequency and (C) coefficient of variation of SNr action currents in
cell-attached recordings from sham (n = 57 cells; 12 mice) and 6-OHDA (n = 44
cells; 11 mice) slices.
(D) sIPSCs recorded in SNr neurons of sham animals (top and middle) during
bath application of the GABAA antagonist gabazine (10 mM) (top), and in a SNr
neuron of a 6-OHDA lesioned mouse (bottom, blue).
(E and F) (E) Amplitude and (F) frequency of sIPSCs recorded in sham (white;
n = 22 cells; 8 mice) and 6-OHDA lesioned mice (blue, n = 27 cells; 11 mice).
**p < 0.01, t test.
(G) Schematic of the brain slice configuration used to record electrically
evoked striatonigral GABA currents in whole-cell patch clamp (top). IPSCs
recorded from SNr neurons at increasing stimulation current applied to the
striatonigral fibers in slices from sham (black) and 6-OHDA (blue)-treated mice
(bottom).
978 Neuron 87, 976–988, September 2, 2015 ª2015 Elsevier Inc.returned to prestimulus levels when illumination of the SNr was
terminated.
Stimulation of the SNr did not induce expression of c-Fos,
an indirect marker for neuronal activity, in MSN cell bodies (Fig-
ures S3A and S3B), suggesting that the behavioral effect did not
involve striatal activation. We found no correlation between the
ChR2 expression level and the number of rotations performed
by the same animal (Figure S3C), confirming that the DA dener-
vation, not the ChR2 expression level, was responsible for the
increased behavioral response observed.
In summary, direct stimulation of the striatonigral synapse
promotes locomotion in 6-OHDA lesioned mice, and chronic
loss of DA leads to a sensitized behavioral response to striato-
nigral activation.
Effect of Dopamine Loss on SNr GABA Transmission
To explore how striatonigral activation leads to sensitized
behavior in DA-depleted mice, we prepared oblique acute
sagittal brain slices containing the striatum, the striatonigral
fibers, and the SNr (Figure 2G). Cell-attached recordings from
principal GABAergic SNr neurons (Figures S4A–S4E) revealed
no differences in firing frequency or pattern of activity (Figures
2A–2C; p > 0.05, Wilcox test), determined as the coefficient of
variation, between DA denervated cells and control mice.
To measure presynaptic function, we recorded spontaneous
synaptic inputs in the presence of NBQX (10 mM) and AP5
(50 mM) to block glutamatergic responses by AMPA and NMDA
receptors, respectively, and loaded SNr neurons with 144 mM
chloride in the pipette solution to facilitate detection of sponta-
neous inhibitory postsynaptic currents (sIPSCs). At –60mV hold-
ing potential, we observed inward currents that were blocked by
the GABAA receptor antagonist gabazine (10 mM), confirming
their identity as GABAA-mediated sIPSCs (Figure 2D). No differ-
ences were observed in the amplitude of sIPSCs between sham
and 6-OHDA lesioned animals, but there was an increased fre-
quency of sIPSCs in 6-OHDA lesioned mice (Figures 2E and
2F). As changes in the frequency of spontaneous synaptic events
are generally considered to reflect presynaptic modifications in
synaptic strength, these results provided a first indication that
DA denervation increased GABA transmission in the SNr by pre-
synaptic enhancement of GABA release.(H) IPSC peak amplitudes as a function of stimulation current in slices from
sham (n = 18 cells, 7 mice) and 6-OHDA (n = 20 cells, 10 mice) treated mice.
*p < 0.05 (two-way ANOVA, Tukey’s test). Mean ± SEM.
(I) Schematic of the brain slice configuration used to record optically evoked
striatonigral GABA currents in whole-cell patch clamp (top panel). ChR2-
evoked inhibition (2 3 1 ms blue flash indicated) of a SNr neuron recorded in
current clamp (bottom panel).
(J) ChR2-evoked picrotoxin-sensitive GABAA currents in voltage-clamped SNr
neurons. Note the pronounced PPF in response to the two flashes (0.5 ms;
50 ms ITI) of blue light.
(K) ChR2-evoked IPSCs recorded in SNr neurons in slices from sham (black)
and 6-OHDA (blue) lesioned mice. Responses are scaled to the initial IPSCs.
(L) The paired-pulse ratio of optically evoked IPSCs recorded in SNr neurons
from sham (white; n = 16 cells, 7 mice at 50 ms ITI and n = 12 cells, 6 mice at
100 ms ITI) and 6-OHDA (blue; n = 15 cells, 6 mice at 50 ms ITI and n = 9 cells,
6 mice at 100 ms ITI) lesioned mice. *p < 0.05, ***p < 0.001, t test (see also
Figure S4).
The sIPSCs recorded in SNr neurons are presumably due to
a combination of GABAA currents elicited by striatonigral, pal-
lidonigral, and local SNr inputs (Deniau et al., 1982; von Krosigk
et al., 1992). In the majority of SNr neurons (53/71) held at
–60 mV with 16 mM Cl– in the pipette solution, distal stimulation
of SNr afferents evoked outward GABAA-mediated IPSCs
(Figures S4F–S4H), with properties equivalent to striatonigral
synapses (Figure S4I) (Connelly et al., 2010; Miyazaki and
Lacey, 1998). These currents were identical to the optogeneti-
cally evoked striatonigral IPSCs (Figure 2J). In a smaller fraction
of SNr cells (18/71), we observed inward GABAA currents with
properties similar to pallidonigral inputs (Figures S4F–S4H)
(Connelly et al., 2010; Miyazaki and Lacey, 1998). For the ma-
jority of these cells (13/18), the inward current was followed by
an outward current (Figure S4F), consistent with observations
that SNr neurons receive convergent inputs from the globus
pallidus (GP) and striatum (von Krosigk et al., 1992). The puta-
tive striatonigral synapses were characterized by longer delay
after stimulation, slower kinetics, and facilitation in response
to paired pulse stimuli (Figure S4I; 50 ms interstimulus inter-
val, ITI). Thus, electrical stimulation evokes striatonigral and
occasionally pallidonigral GABA release; pallidonigral synap-
ses appear to exhibit distinct electrophysiological properties
including inward currents and short delay, providing a means
to isolate the apparent striatonigral component on cells that
received both inputs.
To examine differences in striatonigral input between sham
and 6-OHDA lesioned mice, we used electrical stimulus and
optogenetics (Figures 2G–2I). In SNr neurons filled with high
Cl (144 mM) to increase detection of GABA release, electrical
stimulation evoked IPSCs with striatonigral properties in both
groups, as indicated by the delay after stimulation (sham, 6.4 ±
0.6 ms; 6-OHDA, 6.0 ± 0.3 ms, p > 0.05, t test) and the decay
constant of the synaptic current (sham, 7.1 ± 0.8ms, n = 18 cells;
6-OHDA, 9.3 ± 0.9 ms, p > 0.05, t test). We did not observe any
putative pallidonigral currents. We found a gradual increase in
the amplitude of the IPSCs with increasing current in both
sham and 6-OHDAmice; however, consistent with a potentiated
striatonigral pathway after DA denervation, the IPSCs were
larger in the lesioned mice (Figures 2G and 2H).
In current clamp recordings from principal SNr GABA neurons,
illumination of brain slices from D1-Cre-AAV-ChR2-eYFP mice
with blue light (0.5–1 ms; Figure 2I) interrupted spontaneous
activity, and in voltage clamp recordings, illumination elicited
picrotoxin-sensitive (100 mM) GABAA receptor-mediated synap-
tic currents (Figure 2J). Thus, stimulation of striatonigral inputs
caused GABA release that inhibited SNr tonic firing via activation
of GABAA receptors.
We compared the short-term plasticity evoked by pairs of
striatonigral photostimulation (Figures 2J and 2K). The paired-
pulse ratio (PPR) of the second response to the first determines
the initial release probability of synapses (Zucker and Regehr,
2002). Similar to electrical stimuli (Figure S4I), currents evoked
by pairs of striatonigral photostimulation (50–100 ms ITI) in
sham animals revealed that striatonigral synapses had low
release probability, as indicated by pronounced PPF (Figures
2K and 2L). In contrast, stimuli applied to the SNr in 6-OHDA an-
imals resulted in short-term plasticity representative of synapseswith high release probability; we observed paired-pulse depres-
sion (PPD) at 50 ms ITI, with nearly identical currents in response
to the first and second pulse with 100 ms paired-pulse photo-
stimulation (Figure 2L). There was no rundown of evoked SNr
currents over 5 min of continuous optical stimulation of the
striatonigral fibers at 100 ms ITI (Figure S5), similar parameters
to that used for behavioral experiments (cf. Figures 1 and S2).
We found no clear PPD of IPSCs evoked by electrical stimulation
(50 ms ITI) of the striatonigral fibers in DA denervated animals
(cf. Figure 6F), while observing a significant reduction in PPF;
the PPR was 1.27 ± 0.06, n = 11 cells and 1.09 ± 0.05, n = 7 cells
(p < 0.05, t test) in sham and 6-OHDA lesioned mice, respec-
tively. The differences between electrical and optical stimulation
may be because electrical stimulation is less selective than
optical stimulation or because ChR2 and AAVs used for gene
delivery increase the release probability of synapses (Jackman
et al., 2014; Zhang and Oertner, 2007).
Labeling of Striatonigral Synapses with FM1-43
The patch-clamp experiments suggested that the ability of
the striatonigral pathway to elicit sensitized behaviors in parkin-
sonian animals was due to an increased release probability
of GABA release from striatonigral synapses. Postsynaptic re-
cordings, however, provide an indirect measure of presynaptic
plasticity, and interpretation can be confounded by multiple
postsynaptic mechanisms, including receptor expression, satu-
ration, and desensitization. We therefore developed an optical
approach using the dye FM1-43 to visualize the fusion of recy-
cling synaptic vesicles at individual striatonigral synapses.
FM1-43 acquires a bright fluorescent signal upon incorporation
into the lipid bilayer of recycling synaptic vesicles (Betz and Be-
wick, 1992), and the release probability of individual release sites
can be estimated by the rate of fluorescence decay during stim-
ulus trains (Zakharenko et al., 2001).
To load FM1-43 into striatonigral synapses, we prepared
sagittal slices and applied electrical stimulation to the striatonig-
ral projection (Figures 3A and 3B), and then superfused ADVA-
SEP-7 (100 mM) to remove unbound dye (Kay et al., 1999). Bright
spherical fluorescent puncta with an average diameter of 0.69 ±
0.004 mm (n = 796) were revealed in the SNr by two-photon mi-
croscopy (Figures 3C and S6). Puncta were not present in slices
exposed to FM1-43 in the absence of stimuli (Figure S7A).
FM1-43 unloading was achieved by a second round of stimu-
lation (Figure 3C; Movie S3). When we severed the fibers with a
knife cut after the loading stimulus, the puncta retained FM1-43
fluorescence during the stimuli (Figures S7B–S7E). In contrast,
activity-dependent decrease in FM1-43 fluorescence was
achieved by repositioning the stimulation electrode onto intact
striatonigral fibers caudal to the knife cut (Figures S7B–S7E).
Thus, loading and unloading of FM1-43 required intact projec-
tions from the striatum to the SNr.
To confirm that our FM1-43 loading procedure labeled
striatonigral synapses, we used transgenic mice expressing
tdTomato under control of the D1R promoter (Figures S7F–
S7I), to transduce tdTomato fluorescence in D1-MSNs (Table
S2). tdTomato expression within the SNr was confined to en pas-
sage fibers and DARPP-32 immunopositive profiles (Figure S7F).
In contrast, SNr neurons visualized by Nissl stain did not containNeuron 87, 976–988, September 2, 2015 ª2015 Elsevier Inc. 979
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Figure 3. Two-Photon Imaging of FM1-43 Destaining Visualizes Vesicular Fusion at Individual Striatonigral Synaptic Boutons
(A) Schematic of a sagittal brain slice and placement of the stimulation electrode onto the striatonigral fibers. STR, striatum; GP, lateral globus pallidus;
SNr, substantia nigra reticulata.
(B) Protocol for FM1-43 loading and unloading from striatonigral synapses.
(C) Two-photon images with FM1-43 labeled boutons (arrows) before (40–0 s) and during (0–140 s) electrical stimulation (10 Hz) of the striatonigral pathway. The
electrical stimulus began at 0. Scale, 3 mm.
(D) FM1-43 destaining from striatonigral synapses at 1 Hz (blue circles, n = 116 boutons; 9 slices), 2 Hz (green rectangles, n = 132 boutons; 5 slices), 4 Hz (red
diamonds, n = 285 boutons; 11 slices), and 10 Hz (black triangles, n = 152 boutons; 6 slices) stimulus trains (mean ± SEM).
(E) Dependence of unloading on stimulation frequency. The data were fit by the equation t1/2 = t1/2 (min) + q/f (Zakharenko et al., 2001), where t1/2 is the half-time of
unloading, t1/2 (min) is the minimal half-time at 10 Hz frequency, f is the frequency of stimulation (Hz), and q is a constant. Mean ± SEM (n = 6–67 slices).
(F) FM1-43 destaining from striatonigral terminals in ACSF containing 2 mM (black, n = 38 terminals; 3 slices) or 4 mM Ca2+ (white, n = 137 terminals; 3 slices).
(G) Averaged t1/2 at the different extracellular Ca
2+ concentrations. Data represent mean t1/2 per slice and line shows the group average. **p < 0.01, t test.
(H) Two-photon images of a 1 Hz destaining (upper) and 1 Hz nondestaining puncta (lower). Bottom panel shows the FM1-43 fluorescence of these two boutons.
(I) Ratio of the destaining puncta (filled) at the different extracellular Ca2+ concentrations and stimulation frequencies. Mean ± SEM per slice (n = 3–10 slices per
condition).
(legend continued on next page)
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tdTomato fluorescence. Virtually all FM1-43 puncta showing ac-
tivity-dependent loss of fluorescence colocalized with tdTomato
(97%, 131/134 puncta, n = 5 slices, 3 mice; Figures S7G–S7I),
indicating that the majority of the FM1-43 fluorescent puncta co-
localize with striatonigral projections.
FM1-43 destaining from each bouton is reported as the time
required for the fluorescence intensity to decay to half of its initial
value (t1/2) (Figure S6; Supplemental Experimental Procedures).
The rate of the stimulated FM1-43 destaining was dependent
on the stimulus frequency and exhibited a pronounced slope
between 1 Hz to 4 Hz (Figures 3D and 3E). Destaining of FM1-
43, likeneurotransmitter release,wasdependentonCa2+, asaddi-
tion of Cd2+ (200 mM) to the bath solution to block voltage-gated
Ca2+ channels (VGCC) during unloading arrested exocytosis (Fig-
ure S6E). Consistently, enhancing extracellular Ca2+ from2mM to
4 mM caused more rapid destaining (Figures 3F and 3G).
With 1 Hz stimuli, a significant fraction of boutons maintained
fluorescence (Figure 3H). We could increase the fraction of
active boutons by increasing extracellular Ca2+ (p < 0.001,
Fisher’s exact test, n = 3 slices per group), or stimulating at
2 Hz (p < 0.001, Fisher’s exact test, n = 9 slices per frequency):
at the higher frequency, nearly all boutons exhibited stimulus-
dependent FM1-43 destaining (Figure 3I). Thus, this optical
approach identifies subsets of striatonigral synapses with a
range of release probabilities. Consistent with multiple popula-
tions of striatonigral presynaptic sites, the frequency histogram
(Figure 3J) at 2 Hz unloading stimuli revealed that the t1/2 of
the individual boutons diverged from a normal distribution
(p < 0.0001, KS test, n = 665 boutons, 25 slices). We selected
a stimulus frequency of 2 Hz, the point of highest slope and
thus the dynamic range permitting optimal detection of changes
in destaining (Figure 3E), for further analysis.
Regulation of FM1-43 Destaining by Cannabinoid
Receptor 1 and Stimulus Pattern
To confirm that FM1-43 destaining provided a reliable measure
of presynaptic striatonigral GABA transmission, we explored
the influence of cannabinoid receptor 1 (CB1R), which is spe-
cifically expressed in the SNr by striatonigral efferents (Ma´tya´s
et al., 2006) and has been reported to inhibit striatonigral release
(Wallmichrath and Szabo, 2002). Superfusion of FM1-43-loaded
striatonigral synapses with the specific CB1R agonist ACEA
(10 mM) decreased FM1-43 destaining during unloading (Figures
3K and 3L), an effect blocked by the CB1R antagonist, AM251
(10 mM). Indeed, the rate of destaining was decreased in the
presence of AM251 below control, indicating that CB1Rs are
tonically activated (Romo-Parra et al., 2009).
We thenaskedwhether synaptic vesicle fusionexhibited short-
term plasticity consistent with PPF in the electrophysiological re-(J) Frequency histogram (n = 665; 25 slices) of t1/2 at 2 Hz with a theoretical gamma
blue curve.
(K) FM1-43 destaining in control condition, with the CB1 agonist ACEA (10 mM),
(L) Box plot of CB1R-dependent effects on FM1-43 destaining. *p < 0.05 versus
(M) Pattern of stimulation used to examine frequency-dependent modulation of r
paired pulses (PP), or bursts. The final number of stimuli was identical (480 pulse
(N) FM1-43 destaining from striatonigral terminals during stimuli delivered at 10 (b
slices), or 500 ms (black circles, n = 352 boutons; 7 slices) interstimulus duration
(O) Box plot of fusion events per stimulus, fractional release (f). *p < 0.05, **p < 0.cordings (cf. Figure 2). Following FM1-43 loading, the synapses
were subjected to a range of stimulus patterns with an equivalent
number of stimuli (Figure 3M). As shown in Figure 3N, there was a
more rapid decay of fluorescence in slices subjected to higher
frequency, consistent with an increased number of synaptic ves-
icles that undergo fusion per action potential (Isaacson and Hille,
1997). We observed an increased fractional release when the
samenumber of stimuli was applied at shorter interstimulus inter-
vals, either as paired pulses or in burst-like stimuli (Figure 3O).
These results indicate that higher rates of activity increase the
probability of neurotransmitter release fromD1RMSN synapses.
Effect of DA Denervation on Striatonigral Vesicular
Fusion
We next examined whether DA lesions altered presynaptic activ-
ity. Brain slices were prepared from hypokinetic unilaterally
6-OHDA lesionedmice assessed by the corridor task 4weeks af-
ter surgery. The rate of FM1-43 destaining in 6-OHDA lesioned
mice (t1/2 = 63.7 ± 7.1 s, n = 8 slices, 8 mice) was substantially
faster than in sham animals (t1/2 = 104.0 ± 5.7 s, n = 8 slices,
8 mice; p < 0.001, t test, Cohen’s d = 2.22). There was a shift
in the cumulative probability distribution (Figure 4C) of the t1/2
of individual boutons to lower values in slices from lesioned
mice (p < 0.0001, KS test, n = 183–219, 8 slices per group).
The density of active release sites was indistinguishable be-
tween sham and lesioned mice (p > 0.05, t test, Figure 4D). We
likewise found no difference between the average fluorescence
intensity of the individual synaptic boutons (p > 0.05, t test), or
the amount of fluorescence (DF) lost during unloading (p >
0.05, t test). As FM1-43 loading depends on the number of syn-
aptic vesicles that undergo recycling during stimulation (Harata
et al., 2001), these data indicate that DA denervation enhances
the release probability of the striatonigral pathway without
altering the number of release sites or the total pool of recycling
synaptic vesicles.
We tested whether DA denervation affected CB1R-mediated
responses at the striatonigral synapses (Figure S8). We found
no difference in the ability of CB1R ligands to modulate the t1/2
of FM1-43 destaining between sham and 6-OHDA lesioned
mice (p > 0.05, two-way ANOVA). These results suggest that
the FM1-43 destaining is a measure of striatonigral activity in
sham as well as in 6-OHDA mice.
We examined whether the effects of chronic DA lesion
occurred following acute DA depletion by injecting mice with
reserpine (5 mg/kg s.c.) 13 hr prior to slice preparation, which
depletes >99% of striatal DA content (Bamford et al., 2004a).
The kinetics of FM1-43 destaining in acutely DA depleted mice
(t1/2 = 116.3 ± 10.8, n = 10 slices, 10 mice) were not different
from vehicle (0.1% acetic acid in 0.9% saline)-injected animals-function distribution (shape = 3.07, scale = 38.3, p > 0.05, KS-test) shown as a
or the combination of the CB1 antagonist AM251 (10 mM) and ACEA.
control, yyyp < 0.001 versus ACEA (two-way ANOVA, Tukey’s test).
elease probability. During FM1-43 unloading, stimulation was applied in trains,
s) for each protocol.
lue diamonds, n = 321 boutons; 7 slices), 50 (red rectangles, n = 289 boutons; 7
.
01 versus train (one-way ANOVA, Dunnett’s test) (see also Figures S6 and S7).
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Figure 4. Increased Release Probability at Individual Striatonigral
Synapses in 6-OHDA Lesioned Mice
(A) Micrographs of fluorescent boutons from the SNr of sham (left) and
6-OHDA lesioned (right) mice during unloading of FM1-43. Electrical stimula-
tion was applied at indicated time and frequency (bars).
(B) Mean time course of FM1-43 destaining from striatonigral synapses in
sham (n = 219 boutons, 8 slices) and 6-OHDA lesioned animals in ACSF (n =
183 boutons, 8 slices).
(C) Cumulative probability of the t1/2 of FM1-43 destaining from individual
striatonigral synapses of sham (black) and 6-OHDA-treated (blue) mice. ***p <
0.0001 versus sham (KS test).
(D–F) Box plots of (D) the density of active synaptic boutons per slice, as
defined by FM1-43 destaining, (E) the fluorescence intensity of puncta before
stimulation, and (F) the amount of fluorescence (DF) released during destain-
ing. There were no differences (p > 0.05, t test) between sham (white) and
6-OHDA lesioned (blue) mice of the parameters presented in (D)–(F). Data are
displayed as averages of each slice (see also Figure S8).(t1/2 = 98.3 ± 6.8, n = 10 slices, 10 mice; p > 0.05; t test, data not
shown). Thus, the increased striatonigral release probability
observed in the 6-OHDA lesioned mice is an adaptation to
long-term DA depletion.
Regulation of Striatonigral Vesicular Fusion by GABAB
Receptors
What mechanism might be responsible for increased presyn-
aptic striatonigral activity following long-term loss of DA? One
possibility is that there is altered inhibition by presynaptic
GABAB autoreceptors (Shen and Johnson, 1997). To test this hy-982 Neuron 87, 976–988, September 2, 2015 ª2015 Elsevier Inc.pothesis, the striatonigral synapses were labeled with FM1-43,
and the GABAB antagonist CGP52432 (1 mM) was added during
the unloading stimulus train. CGP52432 greatly enhanced the
destaining rate of FM1-43 from striatonigral boutons in sham
animals (Figure 5A). The cumulative distribution of the individual
boutons of CGP52432-treated slices (p < 0.0001, KS test,
n = 138–219, 6–8 slices) indicated that the majority of
striatonigral synapses were inhibited by tonic GABAB signaling
(Figure 5B).
In stark contrast, there was no effect of inhibiting GABAB re-
ceptors in the lesioned hemisphere of 6-OHDA-injected mice,
and the distributions of t1/2 values were nearly identical in un-
treated and CGP52432-treated slices (p > 0.05, KS-test, n =
183–201 boutons, 5–8 slices). While 6-OHDA lesioned mice
showed faster destaining of striatonigral presynaptic sites, the
stimulatory effect of GABAB-receptor blockade was completely
abolished (Figure 5E).
Together, these data suggest that the increased striatonigral
release probability following DA lesion involves loss of tonic pre-
synaptic GABAB-mediated inhibition.
Regulation of Striatonigral Transmission by GABAB
Receptors
To examine how presynaptic loss of GABAB inhibition affects
striatonigral GABA transmission, we measured the effect of
GABAB antagonism on electrically evoked outward GABAA cur-
rents in voltage-clamped SNr neurons (Figure 6A). Cesium was
included in the pipette solution to minimize GABAB-mediated
postsynaptic effects through GIRK channels, and NBQX
(10 mM) and AP5 (50 mM) were added to isolate GABAA-recep-
tor-mediated IPSCs.
In control slices, CGP52432 (1 mM) substantially increased the
amplitude of the evoked IPSCs of sham animals (Figures 6B–6D).
The antagonist increased the IPSCs elicited by the first (p < 0.05,
t test) and second (p < 0.001, t test) pulse of paired-pulse stimuli
(50 ms ITI). We found a larger increase (p < 0.01, t test) on the
second eIPSC (25.2 ± 4.9 pA) than the first (11.4 ± 4.9 pA).
In striking contrast to controls, in slices from 6-OHDA lesioned
mice, CGP52432 (1 mM) had no effect on the amplitude of either
eIPSC of the paired pulse stimulus (Figures 6B, 6E, and 6F; first
eIPSC, p > 0.05; second eIPSC, p > 0.05, t test).
These results suggest that normal presynaptic GABAB-
mediated inhibition of striatonigral release is abolished by DA
denervation.
Effect of GABAB Receptor Stimulation on Striatonigral
Release
To address how DA denervation alters GABAB function, we
examined inhibition of FM1-43 unloading from sham-treated
striatonigral synapses by the GABAB agonist, baclofen
(1, 10mM) (Figures 7Aand 7B). In the presence of 10mMbaclofen,
only a few puncta destainedwith 2 Hz stimuli; however, the same
boutons displayed rapid synaptic vesicle fusion in response to
10 Hz stimuli. The effect of baclofen was blocked by preapplica-
tion of the GABAB antagonist CGP52432 (1 mM).
In DA lesioned mice, baclofen (1 mM) also inhibited syn-
aptic vesicle exocytosis (Figure 7C), although the effect was
substantially reduced. The number of active presynaptic sites
A B
C D
E
Figure 5. Reduced GABAB Mediated Tonic Inhibition of Vesicle
Fusion at Striatonigral Synapses of 6-OHDA Lesioned Mice
(A) FM1-43 destaining from individual striatonigral synapses in slices from
sham-treated mice in ACSF (circles, n = 219 boutons, 8 slices) or CGP52432
(cgp, 1 mM, squares, n = 138 boutons, 6 slices).
(B) Cumulative probability distribution of the t1/2 of FM1-43 destaining from
individual striatonigral synapses of sham-treated mice in ACSF (solid line) and
in CGP52432 (dashed line). ***p < 0.0001 versus ACSF (KS test).
(C) FM1-43 destaining in 6-OHDA lesioned mice in ACSF (circles, n = 183
boutons, 8 slices) or with CGP52432 (1 mM, squares, n = 201 boutons, 5 slices).
(D) Cumulative probability distribution of the t1/2 of FM1-43 destaining from
striatonigral synapses in 6-OHDA lesioned mice in normal ACSF (solid line) or
CGP52432 (1 mM).
(E) Box plot of mean FM1-43 destaining rates (t1/2) in sham (white) and 6-OHDA
lesioned mice, with or without CGP52432 (1 mM) during unloading. **p < 0.01,
***p < 0.001 versus sham ACSF (two-way ANOVA, Tukey’s test).
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Figure 6. Reduced GABAB Mediated Tonic Inhibition of GABA
Release in 6-OHDA Lesioned Mice
(A) Schematic of the sagittal slice preparation and positioning of the electrode
used to evoke and record GABA release from striatonigral synapses.
(B) Evoked IPSCs recorded in voltage-clamped SNr neurons during baseline
(black) and 10min after application of CGP52432 (1 mM; blue) in sham (left) and
6-OHDA lesioned (right) mice.
(C–F) (C and E) Normalized IPSC peak amplitude of the first (black) and second
(red) stimulus pulse during baseline and application of CGP52432 (1 mM) to
slices from (C) sham and (E) 6-OHDA-treated mice. Mean IPSC peak current
amplitude for pulse 1 and 2 in baseline condition and following application of
CGP52432 (1 mM) are displayed for (D) sham and (F) 6-OHDA lesioned mice.
Individual cells are displayed as gray circles, and the means (±SEM) for
baseline (black) and CGP52432 (blue) are displayed as squares. ns, p > 0.05,
*p < 0.05, ***p < 0.001 versus baseline (paired t test).(cf. Figure S7D) was identical in sham and DA-denervated sli-
ces (p > 0.05, one-way ANOVA). The fraction of boutons that
responded to 2 Hz versus 10 Hz stimuli in baclofen was
substantially higher in lesioned mice (Figures 7D and 7E),
confirming decreased GABAB inhibition. The response toGABAB activation was, however, not absent in lesioned
mice, as indicated by a significant reduction in destaining
(Figure 7F). In addition, immunoblotting for GABAB receptors
revealed no changes in GABAB receptor expression in the
SNr on the DA denervated side compared to the intact side
of the same animals (97% ± 7%, p > 0.05, t test; not shown).
We conclude that tonic GABAB-mediated inhibition of the
striatonigral pathway is lost in the 6-OHDA lesioned mice,
but that the GABAB-receptor expression remains in the DA
denervated SNr.Neuron 87, 976–988, September 2, 2015 ª2015 Elsevier Inc. 983
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Figure 7. Inhibition of Synaptic Vesicle
Fusion at Striatonigral Synapses by GABAB
Receptors in Sham and 6-OHDA Lesioned
Mice
(A) Two-photon micrographs of FM1-43-labeled
synaptic boutons in a control slice (upper panel) and
in a slice with baclofen (bac; 10 mM) added to the
ACSF. Stimulation occurred at indicated intervals.
(B) FM1-43 destaining from striatonigral synapses
in slices from sham mice, in control conditions
(ACSF, black circles, n = 122 boutons, 5 slices)
and in the presence of baclofen (1–10 mM, white
circles and diamonds, n = 164–396 boutons; 5–11
slices) with or without CGP52432 (1 mM, gray di-
amonds, n = 138 boutons; 5 slices). Mean ± SEM.
(C) FM1-43 destaining from striatonigral synapses
in slices from 6-OHDA mice in ACSF (blue
circles, n = 203; 8 slices) and ACSF with baclofen
(1 mM, n = 127 terminals, white circles, 4 slices).
Mean ± SEM.
(D) Bar graph of the number of active terminals,
as determined by FM1-43 unloading. The filled
portion of the bars reports average number of
boutons destaining in response to 2 Hz, and
the open portion shows the average number
of boutons that do not destain at 2 Hz but
destain with subsequent 10 Hz stimuli. The bar
height indicates the average number of active
boutons per slice (±SEM). Baclofen (1, 10 mM)
decreased the number of destaining synapses at
2 Hz, but a subsequent 10 Hz stimulus train
revealed no difference in the total number of
active boutons between groups (p > 0.05, one-
way ANOVA).
(E) Box plot indicating the fraction of boutons
destaining in response to 2 Hz unloading stimu-
lation. Baclofen caused a decrease in the ratio of
the boutons activated by 2 Hz that was occluded
by CGP52432 (1 mM). With 1 mM baclofen, the
ratio was higher in slices from 6-OHDA-treated
mice. ***p < 0.001 versus ACSF, yyy p < 0.001 versus baclofen 10 mM, ###p < 0.001 versus sham baclofen 1 mM (two-way ANOVA, Tukey’s test).
(F) Box plot of FM1-43 destaining rates (t1/2) in control and baclofen-treated slices from sham and 6-OHDA mice during 2 Hz unloading stimulation. Baclofen
decreased the release probability in sham as well as 6-OHDA lesioned mice. **p < 0.01, ***p < 0.001 versus ACSF (two-way ANOVA, Tukey’s test).DISCUSSION
Using selective optogenetic stimulation of striatonigral pathway
synapses in vivo, we found that DA denervation sensitized stria-
tonigral-mediated stimulation of motor activity in hemiparkinso-
nian mice. From optical and electrophysiological recordings
of individual synapses within the SNr, we discovered that the
behavioral abnormalities were associated with an increased
GABA transmission in the striatonigral pathway that was due to
a decreased presynaptic GABAB response. Thus, altered striato-
nigral synaptic activity plays an important role in parkinsonian
symptoms and the sensitized responses that occur in PD ther-
apy (Figure 8).
Our data reveal an increased excitability of the striatonigral
synapse in DA lesioned mice, consistent with observations that
D1R ligands administered into striatum (Fletcher and Starr,
1987) or SNr (Kozlowski and Marshall, 1980) induce more
vigorous rotational behavior in DA lesioned than intact animals,
and that intracerebral administration of DA is effective only984 Neuron 87, 976–988, September 2, 2015 ª2015 Elsevier Inc.following DA lesion (Fletcher and Starr, 1987). These effects
are classically attributed to increased behavioral sensitivity to
DA receptor stimulation (Schwarting and Huston, 1996). By
selectively driving synaptic output of D1R MSNs using ChR2,
we find, however, that DA denervated animals display increased
contralateral rotational behavior via a mechanism independent
of DA receptor stimulation. Importantly, this increased behav-
ioral response occurred in animals that had no prior exposure
to DA receptor ligands. We thus hypothesize that while hypoac-
tivity of D1R MSNs observed in vivo is due to loss of D1R-medi-
ated modulation of striatonigral MSN activity (Mallet et al., 2006),
reduced GABAB-mediated presynaptic inhibition results in stria-
tonigral facilitation and increased GABA release during synaptic
activity (Figure 8). To our knowledge, this provides a first direct
demonstration of a compensatory increase in striatonigral syn-
aptic activity in parkinsonian conditions that is independent of
DA receptor activation.
D1R MSN activation can elicit antiparkinsonian (Kravitz et al.,
2010), reinforcing (Kravitz et al., 2012) and rewarding responses
Figure 8. Striatonigral Mediated Motor Sensitization in PD
In normal intact brain (left panel), stimulation of the striatonigral MSNs in the
presence of D1R agonists including DA provides normal GABA release in the
SNr, which activates postsynaptic GABAA receptors and inhibits SNr firing.
This disinhibits thalamocortical synapses and triggers the initiation of move-
ment. At the striatonigral synapse, GABA also inhibits release from striatonigral
synapses via presynaptic GABAB receptors. Together, postsynaptic GABAA
and presynaptic GABAB activation define the kinetics of striatonigral control of
SNr outputs and enable appropriate selection of motor behaviors. In the
parkinsonian brain (right panels), midbrain DA neurons have degenerated and
DA is not available to regulate striatonigral activity. This leads to atypical firing
patterns in SNr and causes motor disabilities. Furthermore, the presynaptic
inhibition of striatonigral release by GABAB receptors is lost, disrupting the
normal control of SNr activity. As a consequence, when striatonigral synapses
are stimulated, an abnormally high level of GABA release is triggered, leading
to sustained inhibition and changes in firing patterns of SNr neurons. This
results in a sensitized motor response that may produce the undesired side
effects of L-DOPA therapy in PD.(Ferguson et al., 2011; Hikida et al., 2010). Here, we find that
stimulation of GABA release from the striatonigral synapse
reduces parkinsonism, suggesting that both striatal and
nigral activation of the striatonigral pathway restore motor ac-
tivity in DA denervated animals. Striatonigral and striatopallidal
MSNs are associated by reciprocal axon collaterals (Tunstall
et al., 2002) that are modulated by DA (Guzma´n et al., 2003)
and dysregulated in PD models (Taverna et al., 2008), and
maintain synaptic connections with cholinergic interneurons
(Chuhma et al., 2011) that may modulate striatal output activity
via MSNs, and GABAergic interneurons (English et al., 2012).
Thus, selective stimulation of striatal neurons can affect
behavior via complex networks, a feature of less concern in
the SNr, where the striatonigral synapses directly influence
basal ganglia output. In support of local action of the optoge-
netic stimulation applied to the striatonigral efferents, we
observed no activation of c-Fos in the striatum. We thus
demonstrate that selective stimulation of the D1R MSNs synap-
ses in SNr can drive behavior, suggesting that local pharmaco-
logical manipulation of these presynaptic sites may correct the
hypokinetic symptoms of PD.To directly measure presynaptic striatonigral activity, we
adapted an optical approach previously developed to examine
individual Schaffer collateral hippocampal (Zakharenko et al.,
2001) and corticostriatal synapses (Bamford et al., 2004b) using
an endocytic fluorescent probe, FM1-43, thatmeasures synaptic
vesicle exocytosis (Betz and Bewick, 1992). FM1-43 unloading
from D1R expressing MSN axon terminals was dependent on
intact connections from the rostral forebrain to the SNr (Fig-
ure S7), on Ca2+ influx (Figure S6), and was inhibited by CB1R
that are specifically expressed by striatonigral efferents (Fig-
ures 3 and S8). In addition, FM1-43 unloading displayed the
same features of short-term plasticity as in electrophysiological
recordings of SNr neurons, including PPF (Figure 3).
The selective FM1-43 labeling of striatonigral synapses was
unexpected, since stimulation of the descending fibers ap-
peared to activate pallidonigral efferents and SNr neurons have
tonically active axon collaterals (Rick and Lacey, 1994). The
apparent lack of significant label at those sites may be because
the labeled synaptic vesicles undergo exocytosis during the
wash period (>20 min). Furthermore, FM1-43-labeled boutons
did not form visible contact with cell bodies. This pattern of
labeled synapses is consistent with the organization of striato-
nigral efferents, which provide small synaptic contacts with
fine distal dendrites of SNr projection neurons, in contrast to pal-
lidonigral inputs that make large basket-shaped synapses on
proximal dendrites and soma (von Krosigk et al., 1992).
The increased striatonigral function in DA denervated animals
was not reproduced by reserpine, indicating that the synaptic
plasticity results from long-term loss of DA signaling. In the DA
intact brain, the striatonigral pathway is controlled by D1Rs on
direct pathway MSNs dendrites as well as on axon terminals
within the SNr (Altar and Hauser, 1987). The coupling of the
D1R to the adenylyl cyclase/protein kinase A/DARPP-32
cascade permits widespread effects on neuronal excitability
and subsequent neurotransmitter release (Svenningsson et al.,
2004) that may account for the DA receptor-independent effects
observed in our study. Indeed, DA depletion changes the gene
expression of voltage-gated potassium and VGCC (Meurers
et al., 2009), providing molecular links to the increased excit-
ability of D1R MSN (Fieblinger et al., 2014; Warre et al., 2011)
and increased GABA release at the striatonigral synapse. The
SNrmay act as a central locus for denervation-induced changes,
leading to sensitization to L-DOPA. Homeostatic changes can
exist in SNr neurons controlled by D1/5 heteroreceptors (Zhou
et al., 2009). Exaggerated effects of DA would be expected
when feedback regulation of extracellular DA via D2R and DAT
expressed by SNc dendrites in the SNr are lost. Indeed, rota-
tional behavior to L-DOPA in 6-OHDA-injected rats is decreased
by local administration of D1R antagonists to the SNr (Robertson
and Robertson, 1989), and the in vivo DA levels produced by
L-DOPA are higher in the SNr of lesioned than intact animals
(Lindgren et al., 2010). Our experiments did not reveal changes
in the firing properties of SNr neurons, which suggests that
GABA release from axon collaterals of SNr neurons is unaffected
by the DA denervation itself. Differences in GABA release could
appear in response to D1R stimulation, however, as indicated by
the ability of D1R agonists to increase the frequency of sIPSCs in
SNr cells of 6-OHDA-treated mice (Mango et al., 2014).Neuron 87, 976–988, September 2, 2015 ª2015 Elsevier Inc. 985
While electrophysiology and imaging experiments demon-
strated a reduced GABAB-mediated control of GABA release
in DA denervated animals, no lesion-induced alterations in
GABAB receptor expression were found. The effects on GABAB
receptor function may occur at the coupling to G-proteins and/
or second messenger signaling, including increased expression
of Golf (Corvol et al., 2004), adenylyl cyclase V/VI (Rangel-Barajas
et al., 2011), or reduced phosphodiesterase-mediated hydroly-
sis of cAMP (Mango et al., 2014). Consistently, GABA release
in the SNr is enhanced by the adenylyl cyclase activator, forsko-
lin (Radnikow and Misgeld, 1998). Alternatively, decreased
GABAB function could arise from altered interactions of Gbg
and N-, P/Q-type VGCC, a mechanism by which GABAB recep-
tors inhibit neurotransmitter release (Bettler and Tiao, 2006). A
role for a VGCC-dependent mechanism is consistent with our
observation that inhibition of vesicular fusion by baclofen was
overcome at higher frequencies of synaptic activity (10 Hz; cf.
Figure 7). A similar phenomenon at hippocampal synapses
(Isaacson and Hille, 1997) was attributed to a dissociation of
the Gbg complex from its binding to VGCC during strong synap-
tic stimulation. Future studies will be required to fully charac-
terize the molecular mechanisms by which GABAB receptors
control GABA release in normal and DA-denervated SNr.
The goal of current symptomatic therapies for PD is to
restore DA function within the striatum. In contrast, our data
indicate that antiparkinsonian effects and the expression of
sensitization, classically considered DA-mediated responses,
can be achieved independently from DA receptor activation
by modulation of the striatonigral pathway within the SNr.
These findings suggest that future PD therapeutics might be
aimed at controlling the activity of SNr neurons. Increased
stimulus-dependent activity of the striatonigral pathway may
represent a mechanism whereby L-DOPA causes dyskinesias,
impulse control disorders, or DA dysregulation syndrome in
PD patients. If so, treatments re-establishing appropriate pre-
synaptic modulation GABA release at the striatonigral synapse
may be clinically beneficial. Our findings suggest that strate-
gies that restore tonic inhibition via GABAB receptors or stim-
ulation of CB1R may reduce adverse effects of L-DOPA in the
treatment of PD.EXPERIMENTAL PROCEDURES
All experiments were approved by the Institutional Animal Care and Use
Committee (IACUC) at the Columbia University. Unilateral injections of
6-OHDA or vehicle, and adeno-associated viruses carrying the genes for
ChR2 and eYFP proteins, were performed by craniotomy in adult BAC-D1
mice or C57Bl/6J mice. Experiments were carried out 3–4 weeks after
surgery. All 6-OHDA-treated mice were tested for DA-denervation-induced
parkinsonian symptoms using the corridor test. For optogenetic control of
motor behavior, blue light (473 nm, 10 mW) was delivered through an optic
fiber implanted into the SNr.
Sagittal brain slices were prepared from DA-depleted and sham control
mice and incubated for 15 min in ACSF containing FM1-43 (10 mM), NBQX
(10 mM), and AP-5 (50 mM). Striatonigral fibers were then stimulated 5 min at
10 Hz to incorporate FM1-43 into recycling synaptic vesicles (Figure 3). To pro-
vide full labeling of the recycling vesicles, FM1-43 was present for 1 min after
the loading stimulus. The same loading protocol was applied throughout the
study. Following wash with ACSF containing ADVASEP-7 (100 mM, Biotium),
the fusion of FM1-43-labeled vesicles in SNr was measured during a second986 Neuron 87, 976–988, September 2, 2015 ª2015 Elsevier Inc.electrical stimulus of variable frequencies (1–10 Hz) in the same position.
Finally, following 3 min of inactivity, the synapses were subjected to 10 Hz
stimuli for 2 min to deplete any pool of remaining labeled vesicles.
Statistical analysis and full methods including behavior analysis, description
of solutions, equipment, and recording procedures for FM1-43 destaining and
patch clamp electrophysiology can be found in Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes eight figures, three tables, three movies,
and Supplemental Experimental Procedures and can be found with this article
at http://dx.doi.org/10.1016/j.neuron.2015.08.022.
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